Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09SYD
|
|||
Drug Name |
Pyrazolo[1,5-a]pyrimidine derivative 26
|
|||
Synonyms |
PMID28270010-Compound-Figure9-3
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ARRAY BIOPHARMA INC. HAAS, Julia ANDREWS, Steven, W. JIANG, Yutong ZHANG, Gan
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H27FN6O3
|
|||
Canonical SMILES |
COC1=C(C=C(C=C1)F)C2CCCN2C3=NC4=C(C=NN4C=C3)NC(=O)N5CCCC(C5)O
|
|||
InChI |
1S/C23H27FN6O3/c1-33-20-7-6-15(24)12-17(20)19-5-3-10-29(19)21-8-11-30-22(27-21)18(13-25-30)26-23(32)28-9-2-4-16(31)14-28/h6-8,11-13,16,19,31H,2-5,9-10,14H2,1H3,(H,26,32)/t16-,19+/m0/s1
|
|||
InChIKey |
RGIQATAASXNYCK-QFBILLFUSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Tropomyosin-related kinase A (TrkA) | Target Info | Inhibitor | [1] |
Target's Patent Info | Tropomyosin-related kinase A (TrkA) | Target's Patent Info | [1] | |
KEGG Pathway | MAPK signaling pathway | |||
Endocytosis | ||||
Apoptosis | ||||
Neurotrophin signaling pathway | ||||
Inflammatory mediator regulation of TRP channels | ||||
Pathways in cancer | ||||
Transcriptional misregulation in cancer | ||||
Thyroid cancer | ||||
Central carbon metabolism in cancer | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | Neurotrophic factor-mediated Trk receptor signaling | |||
Reactome | Frs2-mediated activation | |||
ARMS-mediated activation | ||||
NGF-independant TRKA activation | ||||
PI3K/AKT activation | ||||
WikiPathways | MAPK Signaling Pathway | |||
BDNF signaling pathway | ||||
Integrated Pancreatic Cancer Pathway | ||||
NGF signalling via TRKA from the plasma membrane |
References | Top | |||
---|---|---|---|---|
REF 1 | Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.Expert Opin Ther Pat. 2017 Jun;27(6):733-751. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.